OYST
Oyster Point Pharma, Inc. Common Stock
OYST
OYST
Delisted
OYST was delisted on the 30th of December, 2022.
60 hedge funds and large institutions have $87.5M invested in Oyster Point Pharma, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 17 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
64% less capital invested
Capital invested by funds: $246M → $87.5M (-$159M)
Holders
60
Holding in Top 10
2
Calls
$17K
Puts
–
Top Buyers
| 1 | +$1.5M | |
| 2 | +$910K | |
| 3 | +$583K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$509K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$248K |
Top Sellers
| 1 | -$3.03M | |
| 2 | -$2.42M | |
| 3 | -$1.34M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
-$1.25M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$715K |